- Home
- REKR vs ONCY Comparison
REKR vs ONCY Comparison
Compare REKR & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REKR
- ONCY
- Stock Information
- Founded
- REKR 2017
- ONCY 1998
- Country
- REKR United States
- ONCY Canada
- Employees
- REKR N/A
- ONCY N/A
- Industry
- REKR Telecommunications Equipment
- ONCY Pharmaceuticals and Biotechnology
- Sector
- REKR Telecommunications
- ONCY Health Care
- Exchange
- REKR Nasdaq
- ONCY Nasdaq
- Market Cap
- REKR 79.8M
- ONCY 86.1M
- IPO Year
- REKR N/A
- ONCY 1999
- Fundamental
- Price
- REKR $0.84
- ONCY $0.77
- Analyst Decision
- REKR Buy
- ONCY Strong Buy
- Analyst Count
- REKR 1
- ONCY 2
- Target Price
- REKR N/A
- ONCY $4.00
- AVG Volume (30 Days)
- REKR 903.8K
- ONCY 359.4K
- Earning Date
- REKR 11-14-2024
- ONCY 11-12-2024
- Dividend Yield
- REKR N/A
- ONCY N/A
- EPS Growth
- REKR N/A
- ONCY N/A
- EPS
- REKR N/A
- ONCY N/A
- Revenue
- REKR $43,817,000.00
- ONCY N/A
- Revenue This Year
- REKR $33.40
- ONCY N/A
- Revenue Next Year
- REKR $41.09
- ONCY N/A
- P/E Ratio
- REKR N/A
- ONCY N/A
- Revenue Growth
- REKR 44.46
- ONCY N/A
- 52 Week Low
- REKR $0.79
- ONCY $0.76
- 52 Week High
- REKR $3.92
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- REKR 41.80
- ONCY 26.96
- Support Level
- REKR $0.81
- ONCY $0.91
- Resistance Level
- REKR $0.88
- ONCY $0.88
- Average True Range (ATR)
- REKR 0.07
- ONCY 0.04
- MACD
- REKR 0.00
- ONCY -0.01
- Stochastic Oscillator
- REKR 25.34
- ONCY 11.12
About REKR Rekor Systems Inc.
Rekor Systems Inc is a United States-based company. The company is engaged in providing real-time roadway intelligence through AI-driven decisions. The firm uses artificial intelligence to analyze video streams and transform them into AI-driven decisions. The company's technology and machine learning models power all solutions, including Rekor Command for transportation management, Rekor Discover for urban mobility, and Rekor Scout for public safety, and commercial use. Its geographical segments are the United States and Others, of which the majority of its revenue comes from the United States.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.